Vascular complications during TAVR: The cost of doing business.

  • Robert D Safian
  • Published 2014 in
    Catheterization and cardiovascular interventions…

Abstract

Transcatheter aortic valve replacement (TAVR) has proven superiority to standard medical therapy in inoperable patients with symptomatic severe aortic stenosis, and is equivalent to surgical AVR in high-risk patients [1,2]. Although two devices are currently available in the United States for commercial or investigational use, there are more than 15 devices… (More)
DOI: 10.1002/ccd.25340

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.